298 related articles for article (PubMed ID: 8956997)
21. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
[TBL] [Abstract][Full Text] [Related]
22. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
Bennett JD; Farlie PG; Watson RJ
Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
[TBL] [Abstract][Full Text] [Related]
23. Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation.
Richon VM; Lyle RE; McGehee RE
J Biol Chem; 1997 Apr; 272(15):10117-24. PubMed ID: 9092557
[TBL] [Abstract][Full Text] [Related]
24. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
[TBL] [Abstract][Full Text] [Related]
25. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
Halaban R; Cheng E; Smicun Y; Germino J
J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
[TBL] [Abstract][Full Text] [Related]
26. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.
Sellers WR; Novitch BG; Miyake S; Heith A; Otterson GA; Kaye FJ; Lassar AB; Kaelin WG
Genes Dev; 1998 Jan; 12(1):95-106. PubMed ID: 9420334
[TBL] [Abstract][Full Text] [Related]
27. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors.
Kalejta RF; Bechtel JT; Shenk T
Mol Cell Biol; 2003 Mar; 23(6):1885-95. PubMed ID: 12612064
[TBL] [Abstract][Full Text] [Related]
28. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction.
Swenson JJ; Mauser AE; Kaufmann WK; Kenney SC
J Virol; 1999 Aug; 73(8):6540-50. PubMed ID: 10400750
[TBL] [Abstract][Full Text] [Related]
29. Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins.
Pajovic S; Wong EL; Black AR; Azizkhan JC
Mol Cell Biol; 1997 Nov; 17(11):6459-64. PubMed ID: 9343408
[TBL] [Abstract][Full Text] [Related]
30. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
[TBL] [Abstract][Full Text] [Related]
31. E2F-4, a new member of the E2F transcription factor family, interacts with p107.
Ginsberg D; Vairo G; Chittenden T; Xiao ZX; Xu G; Wydner KL; DeCaprio JA; Lawrence JB; Livingston DM
Genes Dev; 1994 Nov; 8(22):2665-79. PubMed ID: 7958924
[TBL] [Abstract][Full Text] [Related]
32. Cell cycle-specific association of E2F with the p130 E1A-binding protein.
Cobrinik D; Whyte P; Peeper DS; Jacks T; Weinberg RA
Genes Dev; 1993 Dec; 7(12A):2392-404. PubMed ID: 8253385
[TBL] [Abstract][Full Text] [Related]
33. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
Fattaey AR; Harlow E; Helin K
Mol Cell Biol; 1993 Dec; 13(12):7267-77. PubMed ID: 8246949
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays.
Inman GJ; Farrell PJ
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2141-9. PubMed ID: 7561751
[TBL] [Abstract][Full Text] [Related]
35. Differential activities of E2F family members: unique functions in regulating transcription.
Pierce AM; Schneider-Broussard R; Philhower JL; Johnson DG
Mol Carcinog; 1998 Jul; 22(3):190-8. PubMed ID: 9688145
[TBL] [Abstract][Full Text] [Related]
36. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
Wang S; Nath N; Adlam M; Chellappan S
Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
[TBL] [Abstract][Full Text] [Related]
37. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
Stiegler P; De Luca A; Bagella L; Giordano A
Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
[TBL] [Abstract][Full Text] [Related]
38. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation.
Zalvide J; DeCaprio JA
Mol Cell Biol; 1995 Oct; 15(10):5800-10. PubMed ID: 7565733
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.
Watanabe G; Albanese C; Lee RJ; Reutens A; Vairo G; Henglein B; Pestell RG
Mol Cell Biol; 1998 Jun; 18(6):3212-22. PubMed ID: 9584162
[TBL] [Abstract][Full Text] [Related]
40. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
